Skip to main content
Top
Published in: Respiratory Research 1/2020

Open Access 01-12-2020 | ECMO | Research

Factors associated with intraoperative extracorporeal membrane oxygenation support during lung transplantation

Authors: Rong Zhang, Yonghao Xu, Ling Sang, Sibei Chen, Yongbo Huang, Lingbo Nong, Chun Yang, Xuesong Liu, Dongdong Liu, Yin Xi, Weiqun He, Bing Wei, Jianxing He, Yimin Li, Xiaoqing Liu

Published in: Respiratory Research | Issue 1/2020

Login to get access

Abstract

Background

Intraoperative Extracorporeal membrane oxygenation (ECMO) is increasingly being applied as life-support for lung transplantation patients. However, factors associated with this procedure in lung transplantation patients have not yet been characterized. The aim of this study was to identify preoperative factors of intraoperative ECMO support during lung transplantation and to evaluated the outcome of lung transplantation patients supported with ECMO.

Methods

Patients underwent lung transplantation treated with and without ECMO in Guangzhou Institute of Respiratory Diseases between January 2015 to August 2018 were retrospectively reviewed. Patient demographics and clinical variables were collected and analyzed. Multivariate logistic regression was performed to identify factors independently associated with intraoperative extracorporeal membrane oxygenation support during lung transplantation.

Results

During the study period, 138 patients underwent lung transplantation at our institution, the mean LAS was (56.63 ± 18.39) (range, 32.79 to 88.70). Fourty four patients were treated with veno-venous/veno-arterial ECMO. Among the patients, 32 patients wean successfully ECMO after operation, 12 patients remain ECMO after operation, and 32 patients (62.74%) survived to hospital discharge. In multiple analysis, the following factors were associated with intraoperative ECMO support: advanced age, high PAP before operation, duration of mechanical ventilation before operation, a higher APACHE II and primary diagnosis for transplantation. The overall survival rates at 1, 3, and 12 months were 90.91, 72.73, and 56.81% in the ECMO group, and 95.40, 82.76, and 73.56% in the non-ECMO group, respectively (log-rank P = 0.081). Patients who underwent single lung transplant had a lower survival rates in ECMO group as compared with non-ECMO group at 1, 3, and 12 months (90.47% vs 98.25, 71.43% vs 84.21, and 52.38% vs 75.44%) (log-rank P = 0.048).

Conclusions

The preoperative factors of intraoperative ECMO support during lung transplantation included age, high PAP before operation, preoperative mechanical ventilation, a higher APACHE II and primary diagnosis for transplantation based on multivariate analysis.
Appendix
Available only for authorised users
Literature
1.
go back to reference Yusen RD, Edwards LB, Dipchand AI, Goldfarb SB, Kucheryavaya AY, Levvey BJ, et al. The Registry of the International Society for Heart and Lung Transplantation: Thirty-third Adult Lung and Heart-Lung Transplant Report-2016; Focus Theme: Primary Diagnostic Indications for Transplantl. J Heart Lung Transplant. 2016;35(10):1170–84.CrossRef Yusen RD, Edwards LB, Dipchand AI, Goldfarb SB, Kucheryavaya AY, Levvey BJ, et al. The Registry of the International Society for Heart and Lung Transplantation: Thirty-third Adult Lung and Heart-Lung Transplant Report-2016; Focus Theme: Primary Diagnostic Indications for Transplantl. J Heart Lung Transplant. 2016;35(10):1170–84.CrossRef
2.
go back to reference Weill DBC, Corris PA, Dark JH, Davis RD, Keshavjee S, Lederer DJ, Mulligan MJ, Patterson GA, Singer LG, Snell GI, Verleden GM, Zamora MR, Glanville AR. A consensus document for the selection of lung transplant candidates: 2014--an update from the pulmonary transplantation council of the international society for heart and lung transplantation.l. J Heart Lung Transplant. 2015;34(1):1–15.CrossRef Weill DBC, Corris PA, Dark JH, Davis RD, Keshavjee S, Lederer DJ, Mulligan MJ, Patterson GA, Singer LG, Snell GI, Verleden GM, Zamora MR, Glanville AR. A consensus document for the selection of lung transplant candidates: 2014--an update from the pulmonary transplantation council of the international society for heart and lung transplantation.l. J Heart Lung Transplant. 2015;34(1):1–15.CrossRef
3.
go back to reference Kirklin JK, Cantor R, Mohacsi P, Gummert J, De By T, Hannan MM, et al. First annual IMACS report: a global international society for heart and lung transplantation registry for mechanical circulatory supportl. J Heart Lung Transplant. 2016;35(4):407–12.CrossRef Kirklin JK, Cantor R, Mohacsi P, Gummert J, De By T, Hannan MM, et al. First annual IMACS report: a global international society for heart and lung transplantation registry for mechanical circulatory supportl. J Heart Lung Transplant. 2016;35(4):407–12.CrossRef
4.
go back to reference Abrams D, Brodie D. Extracorporeal membrane oxygenation for adult respiratory failure: 2017 updatel. Chest. 2017;152(3):639–49.CrossRef Abrams D, Brodie D. Extracorporeal membrane oxygenation for adult respiratory failure: 2017 updatel. Chest. 2017;152(3):639–49.CrossRef
5.
go back to reference McFadden PM, Greene CL. The evolution of intraoperative support in lung transplantation: Cardiopulmonary bypass to extracorporeal membrane oxygenationl. J Thorac Cardiovasc Surg. 2015;149(4):1158–60.CrossRef McFadden PM, Greene CL. The evolution of intraoperative support in lung transplantation: Cardiopulmonary bypass to extracorporeal membrane oxygenationl. J Thorac Cardiovasc Surg. 2015;149(4):1158–60.CrossRef
6.
go back to reference Biscotti M, Yang J, Sonett J, Bacchetta M. Comparison of extracorporeal membrane oxygenation versus cardiopulmonary bypass for lung transplantationl. J Thorac Cardiovasc Surg. 2014;148(5):2410–5.CrossRef Biscotti M, Yang J, Sonett J, Bacchetta M. Comparison of extracorporeal membrane oxygenation versus cardiopulmonary bypass for lung transplantationl. J Thorac Cardiovasc Surg. 2014;148(5):2410–5.CrossRef
7.
go back to reference Ius F, Sommer W, Tudorache I, Avsar M, Siemeni T, Salman J, et al. Five-year experience with intraoperative extracorporeal membrane oxygenation in lung transplantation: Indications and midterm resultsl. J Heart Lung Transplant. 2016;35(1):49–58.CrossRef Ius F, Sommer W, Tudorache I, Avsar M, Siemeni T, Salman J, et al. Five-year experience with intraoperative extracorporeal membrane oxygenation in lung transplantation: Indications and midterm resultsl. J Heart Lung Transplant. 2016;35(1):49–58.CrossRef
9.
go back to reference Hoechter DJ, von Dossow V, Winter H, Muller HH, Meiser B, Neurohr C, et al. The munich lung transplant group: intraoperative extracorporeal circulation in lung transplantationl. Thorac Cardiovasc Surg. 2015;63(8):706–14.CrossRef Hoechter DJ, von Dossow V, Winter H, Muller HH, Meiser B, Neurohr C, et al. The munich lung transplant group: intraoperative extracorporeal circulation in lung transplantationl. Thorac Cardiovasc Surg. 2015;63(8):706–14.CrossRef
10.
go back to reference Aigner C, Wisser W, Taghavi S, Lang G, Jaksch P, Czyzewski D, et al. Institutional experience with extracorporeal membrane oxygenation in lung transplantationl. Eur J Cardiothorac Surg. 2007;31(3):468–73 discussion 73-4.CrossRef Aigner C, Wisser W, Taghavi S, Lang G, Jaksch P, Czyzewski D, et al. Institutional experience with extracorporeal membrane oxygenation in lung transplantationl. Eur J Cardiothorac Surg. 2007;31(3):468–73 discussion 73-4.CrossRef
11.
go back to reference Hayanga JWA, Shigemura N, Aboagye JK, Ensor C, Dew MA, Hayanga HK, et al. ECMO support in lung transplantation: a contemporary analysis of hospital charges in the United Statesl. Ann Thorac Surg. 2017;104(3):1033–9.CrossRef Hayanga JWA, Shigemura N, Aboagye JK, Ensor C, Dew MA, Hayanga HK, et al. ECMO support in lung transplantation: a contemporary analysis of hospital charges in the United Statesl. Ann Thorac Surg. 2017;104(3):1033–9.CrossRef
12.
go back to reference George TJBC, Kilic A, et al. Outcomes and temporal trends among high-risk patients after lung transplantation in the United States.l. J Heart Lung Transplant. 2012;31:9.CrossRef George TJBC, Kilic A, et al. Outcomes and temporal trends among high-risk patients after lung transplantation in the United States.l. J Heart Lung Transplant. 2012;31:9.CrossRef
13.
go back to reference Liu X, Xu Y, Zhang R, Huang Y, He W, Sang L, et al. Survival predictors for severe ards patients treated with extracorporeal membrane oxygenation: a retrospective study in chinal. PLoS One. 2016;11(6):e0158061.CrossRef Liu X, Xu Y, Zhang R, Huang Y, He W, Sang L, et al. Survival predictors for severe ards patients treated with extracorporeal membrane oxygenation: a retrospective study in chinal. PLoS One. 2016;11(6):e0158061.CrossRef
14.
go back to reference Anastasios N, Triantafillou MKP, Charles B. Huddleston, Charles G. pond,: predictors, frequency, and indications for cardiopulmonary bypass during lung transplantation in Adultsl. Ann Thorac Surg. 1994;57:1248–51.CrossRef Anastasios N, Triantafillou MKP, Charles B. Huddleston, Charles G. pond,: predictors, frequency, and indications for cardiopulmonary bypass during lung transplantation in Adultsl. Ann Thorac Surg. 1994;57:1248–51.CrossRef
15.
go back to reference de Hoyos ADW, Snell G, Miller J, Winton T, Maurer JR, Patterson GA. Preoperative prediction for the use of cardiopulmonary bypass in lung transplantationl. J Thorac Cardiovasc Surg. 1993;106(5):2.CrossRef de Hoyos ADW, Snell G, Miller J, Winton T, Maurer JR, Patterson GA. Preoperative prediction for the use of cardiopulmonary bypass in lung transplantationl. J Thorac Cardiovasc Surg. 1993;106(5):2.CrossRef
16.
go back to reference Yusen RD, Christie JD, Edwards LB, Kucheryavaya AY, Benden C, Dipchand AI, et al. The registry of the international society for heart and lung transplantation: thirtieth adult lung and heart-lung transplant report--2013; focus theme: agel. J Heart Lung Transplant. 2013;32(10):965–78.CrossRef Yusen RD, Christie JD, Edwards LB, Kucheryavaya AY, Benden C, Dipchand AI, et al. The registry of the international society for heart and lung transplantation: thirtieth adult lung and heart-lung transplant report--2013; focus theme: agel. J Heart Lung Transplant. 2013;32(10):965–78.CrossRef
17.
go back to reference Hayes D Jr, Whitson BA, Black SM, Preston TJ, Papadimos TJ, Tobias JD. Influence of age on survival in adult patients on extracorporeal membrane oxygenation before lung transplantationl. J Heart Lung Transplant. 2015;34(6):832–8.CrossRef Hayes D Jr, Whitson BA, Black SM, Preston TJ, Papadimos TJ, Tobias JD. Influence of age on survival in adult patients on extracorporeal membrane oxygenation before lung transplantationl. J Heart Lung Transplant. 2015;34(6):832–8.CrossRef
18.
go back to reference Brogan TV, Thiagarajan RR, Rycus PT, Bartlett RH, Bratton SL. Extracorporeal membrane oxygenation in adults with severe respiratory failure: a multi-center databasel. Intensive Care Med. 2009;35(12):2105–14.CrossRef Brogan TV, Thiagarajan RR, Rycus PT, Bartlett RH, Bratton SL. Extracorporeal membrane oxygenation in adults with severe respiratory failure: a multi-center databasel. Intensive Care Med. 2009;35(12):2105–14.CrossRef
19.
go back to reference Whelan TP, Dunitz JM, Kelly RF, Edwards LB, Herrington CS, Hertz MI, et al. Effect of preoperative pulmonary artery pressure on early survival after lung transplantation for idiopathic pulmonary fibrosisl. J Heart Lung Transplant. 2005;24(9):1269–74.CrossRef Whelan TP, Dunitz JM, Kelly RF, Edwards LB, Herrington CS, Hertz MI, et al. Effect of preoperative pulmonary artery pressure on early survival after lung transplantation for idiopathic pulmonary fibrosisl. J Heart Lung Transplant. 2005;24(9):1269–74.CrossRef
20.
go back to reference Fang ASS, Kawut SM, et al. Elevated pulmonary artery pressure is a risk factor for primary graft dysfunction following lung transplantation for idiopathic pulmonary fibrosisl. Chest. 2011;139(Issue 4):741–3 4:3. Fang ASS, Kawut SM, et al. Elevated pulmonary artery pressure is a risk factor for primary graft dysfunction following lung transplantation for idiopathic pulmonary fibrosisl. Chest. 2011;139(Issue 4):741–3 4:3.
21.
go back to reference Bermudez CA, Shiose A, Esper SA, Shigemura N, D'Cunha J, Bhama JK, et al. Outcomes of intraoperative venoarterial extracorporeal membrane oxygenation versus cardiopulmonary bypass during lung transplantationl. Ann Thorac Surg. 2014;98(6):1936–42 discussion 42-3.CrossRef Bermudez CA, Shiose A, Esper SA, Shigemura N, D'Cunha J, Bhama JK, et al. Outcomes of intraoperative venoarterial extracorporeal membrane oxygenation versus cardiopulmonary bypass during lung transplantationl. Ann Thorac Surg. 2014;98(6):1936–42 discussion 42-3.CrossRef
22.
go back to reference Hoetzenecker K, Schwarz S, Muckenhuber M, Benazzo A, Frommlet F, Schweiger T, et al. Intraoperative extracorporeal membrane oxygenation and the possibility of postoperative prolongation improve survival in bilateral lung transplantationl. J Thorac Cardiovasc Surg. 2018;155(5):2193–206 e3.CrossRef Hoetzenecker K, Schwarz S, Muckenhuber M, Benazzo A, Frommlet F, Schweiger T, et al. Intraoperative extracorporeal membrane oxygenation and the possibility of postoperative prolongation improve survival in bilateral lung transplantationl. J Thorac Cardiovasc Surg. 2018;155(5):2193–206 e3.CrossRef
23.
go back to reference Ko WJ, Chen YS, Chou NK, Lee YC. ECMO support for single lung transplantationl. Transplant Proc. 2001;33(1–2):1939–41.CrossRef Ko WJ, Chen YS, Chou NK, Lee YC. ECMO support for single lung transplantationl. Transplant Proc. 2001;33(1–2):1939–41.CrossRef
24.
go back to reference Hayes D Jr, Tobias JD, Tumin D. Center volume and extracorporeal membrane oxygenation support at lung transplantation in the lung allocation score eral. Am J Respir Crit Care Med. 2016;194(3):317–26.CrossRef Hayes D Jr, Tobias JD, Tumin D. Center volume and extracorporeal membrane oxygenation support at lung transplantation in the lung allocation score eral. Am J Respir Crit Care Med. 2016;194(3):317–26.CrossRef
Metadata
Title
Factors associated with intraoperative extracorporeal membrane oxygenation support during lung transplantation
Authors
Rong Zhang
Yonghao Xu
Ling Sang
Sibei Chen
Yongbo Huang
Lingbo Nong
Chun Yang
Xuesong Liu
Dongdong Liu
Yin Xi
Weiqun He
Bing Wei
Jianxing He
Yimin Li
Xiaoqing Liu
Publication date
01-12-2020
Publisher
BioMed Central
Keywords
ECMO
ECMO
Published in
Respiratory Research / Issue 1/2020
Electronic ISSN: 1465-993X
DOI
https://doi.org/10.1186/s12931-020-01355-7

Other articles of this Issue 1/2020

Respiratory Research 1/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.